RESUMEN
OBJECTIVE. The purpose of this study was to assess the rate of appendiceal filling with a positive oral contrast solution at MDCT performed for suspected acute appendicitis in adults. MATERIALS AND METHODS. We performed a retrospective review of MDCT in 684 consecutive adult patients with suspected acute appendicitis in a 19-month period. Patients were excluded if no positive oral contrast solution (500 mL each of water and polyethylene glycol and 30 mL diatrizoate) was given or if the appendix was not visible or absent. After exclusion, images of 519 patients (mean age ± SD, 37.4 ± 16.0 years; 335 women, 184 men) were reviewed for cecal contrast opacification and appendiceal filling. Imaging findings were recorded as positive or negative for acute appendicitis using all available clinical and pathologic data as a reference standard. A control series of CT colonography (CTC) screening examinations (overnight preparation with universal cecal opacification) in 2552 adults without symptoms of appendicitis was also reviewed. RESULTS. Cecal opacification was confirmed in 313/519 (60.3%) patients, with no difference between those considered to be positive (68/107, 63.6%) or negative (245/412, 59.5%) for appendicitis (p = 0.506). When positive oral contrast solution reached the cecum, appendiceal filling was seen in none of the 68 (0%) with appendicitis and in 205 of the 245 (83.7%) without appendicitis (p < 0.0001). Among CTC control subjects, appendiceal filling was similar to the cohort considered to be without appendicitis (2240/2552 [87.8%], p = 0.070). CONCLUSION. In MDCT for suspected acute appendicitis, luminal filling of the noninflamed appendix exceeds 80% when positive oral contrast solution reaches the cecum, indicating results similar to screening CTC. The appendix did not fill in proven acute appendicitis, indicating appendiceal filling may allow exclusion of appendicitis with high certainty. These results suggest positive oral contrast solution may augment diagnostic accuracy and confidence in cases of suspected acute appendicitis.
Asunto(s)
Apendicitis/diagnóstico por imagen , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Tomografía Computarizada Multidetector , Administración Oral , Adulto , Colonografía Tomográfica Computarizada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , WisconsinRESUMEN
BACKGROUND AND OBJECTIVES: Practice guidelines for preoperative fasting have not clearly established the fasting time needed after oral administration of water-soluble contrast media. The aim of this study was to determine the time required for the gastric emptying during the water-soluble contrast media in patients with acute abdominal pain. METHODS: This prospective longitudinal study included sixty-eight patients older than 18 years of age with acute abdominal pain, who required a water-soluble contrast media enhanced abdominal computed tomography study. Plain radiographs were obtained hourly until complete the gastric emptying. Patients with probable bowel obstruction were not included in the study. RESULTS: A total of 31 (45,6%), 54 (79,4%), and 64 (94,1%) patients achieved a complete gastric clearance of barium in 1, 2 and 3 hours, respectively. All patients achieved complete emptying of water-soluble contrast media within 6 hours. Gastric emptying time was not associated with gender (P=0,44), body mass index (P=.35), fasting time prior to water-soluble contrast media intake (P=0,12), administration of opioids in the emergency room (P=0,7), and the presence of comorbidities (P=0,36). CONCLUSION: Ninety-four percent of the patients with acute abdominal pain achieved complete gastric emptying within 3hours after the administration of water-soluble contrast media. All of them achieved complete gastric emptying within 6hours. The results suggested 6hours after oral intake of the contrast media is enough to complete transit of water-soluble contrast media through the stomach and avoid unnecessary risks.
Asunto(s)
Abdomen Agudo/diagnóstico por imagen , Sulfato de Bario/farmacocinética , Medios de Contraste/farmacocinética , Ayuno , Vaciamiento Gástrico , Tomografía Computarizada por Rayos X/métodos , Abdomen Agudo/fisiopatología , Adulto , Sulfato de Bario/administración & dosificación , Diatrizoato/administración & dosificación , Diatrizoato de Meglumina/administración & dosificación , Femenino , Humanos , Estudios Longitudinales , Masculino , Guías de Práctica Clínica como Asunto , Estudios Prospectivos , Factores Sexuales , Solubilidad , Factores de TiempoRESUMEN
Long circulating liposomes entrapping iodinated and radioiodinated compounds offer a highly versatile theranostic platform. Here we report a new methodology for efficient and high-yield loading of such compounds into liposomes, enabling CT/SPECT/PET imaging and 131I-radiotherapy. Methods: The CT contrast agent diatrizoate was synthetically functionalized with a primary amine, which enabled its remote loading into PEGylated liposomes by either an ammonium sulfate- or a citrate-based pH transmembrane gradient. Further, the amino-diatrizoate was radiolabeled with either 124I (t1/2 = 4.18 days) for PET or 125I (t1/2 = 59.5 days) for SPECT, through an aromatic Finkelstein reaction. Results: Quantitative loading efficiencies (>99%) were achieved at optimized conditions. The 124I-labeled compound was remote-loaded into liposomes, with an overall radiolabeling efficiency of 77 ± 1%, and imaged in vivo in a CT26 murine colon cancer tumor model by PET/CT. A prolonged blood circulation half-life of 19.5 h was observed for the radiolabeled liposomes, whereas injections of the free compound were rapidly cleared. Lower accumulation was observed in the spleen, liver, kidney and tumor than what is usually seen for long-circulating liposomes. Conclusion: The lower accumulation was interpreted as release of the tracer from the liposomes within these organs after accumulation. These results may guide the design of systems for controlled release of remote loadable drugs from liposomes.
Asunto(s)
Neoplasias del Colon/diagnóstico por imagen , Neoplasias del Colon/terapia , Medios de Contraste/administración & dosificación , Liposomas/administración & dosificación , Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos , Radiofármacos/administración & dosificación , Radioterapia/métodos , Animales , Neoplasias del Colon/patología , Diatrizoato/administración & dosificación , Modelos Animales de Enfermedad , Radioisótopos de Yodo/administración & dosificación , Ratones , Nanomedicina Teranóstica/métodosRESUMEN
OBJECTIVES: The objective of this study is to compare the palatability of iopamidol and iohexol. METHODS: This was a blinded and randomized trial in which fifty healthy subjects taste tested iopamidol (Isovue, Bracco Diagnostics), iohexol (Omnipaque, GE Healthcare), diatrizoate meglumine and diatrizoate sodium solution (Gastrografin, Bracco Diagnostics), and barium sulfate suspension 2.1% w/v, 2.0% w/w (READI-CAT2, E-Z-EM). Participants scored palatability on a continuous scale from 0 to 40 (0 = intolerable, 10 = unpleasant but tolerable, 20 = neutral, 30 = kind of like, 40 = strongly like). RESULTS: Mean scores (SD/SEM) for the contrast agents (n = 50) were iopamidol = 21.0 (8.4/1.2); iohexol = 21.8 (7.1/1.0); Gastrografin = 16.8 (9.6/1.4); and barium = 23.7 (9.1/1.3). One-way ANOVA equality of means test shows rejection of the hypothesis that the means are equal (F* = 6.550, p = .000). Post hoc testing demonstrates Gastrografin to be significantly less preferred to barium (p = .000) and iohexol (p = .012). No difference was found between iopamidol and iohexol (p = .959). One-way ANOVA equality of means test of just iopamidol, iohexol, and barium does not reject the hypothesis that means are equal (F* = 1.778 and p = .174). CONCLUSION: There is no significant difference in palatability between iopamidol and iohexol, supporting the use of iopamidol as a viable alternative to iohexol as an oral contrast agent.
Asunto(s)
Sulfato de Bario/administración & dosificación , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Yohexol/administración & dosificación , Yopamidol/administración & dosificación , Gusto , Tomografía Computarizada por Rayos X , Administración Oral , Adulto , Femenino , Humanos , MasculinoRESUMEN
AIM: To assess the cleansing efficacy and safety of a new Colon capsule endoscopy (CCE) bowel preparation regimen. METHODS: This was a multicenter, prospective, randomized, controlled study comparing two CCE regimens. Subjects were asymptomatic and average risk for colorectal cancer. The second generation CCE system (PillCam® COLON 2; Medtronic, Yoqneam, Israel) was utilized. Preparation regimens differed in the 1st and 2nd boosts with the Study regimen using oral sulfate solution (89 mL) with diatrizoate meglumine and diatrizoate sodium solution ("diatrizoate solution") (boost 1 = 60 mL, boost 2 = 30 mL) and the Control regimen oral sulfate solution (89 mL) alone. The primary outcome was overall and segmental colon cleansing. Secondary outcomes included safety, polyp detection, colonic transit, CCE completion and capsule excretion ≤ 12 h. RESULTS: Both regimens had similar cleansing efficacy for the whole colon (Adequate: Study = 75.9%, Control = 77.3%; P = 0.88) and individual segments. In the Study group, CCE completion was superior (Study = 90.9%, Control = 76.9%; P = 0.048) and colonic transit was more often < 40 min (Study = 21.8%, Control = 4%; P = 0.0073). More Study regimen subjects experienced adverse events (Study = 19.4%, Control = 3.4%; P = 0.0061), and this difference did not appear related to diatrizoate solution. Adverse events were primarily gastrointestinal in nature and no serious adverse events related either to the bowel preparation regimen or the capsule were observed. There was a trend toward higher polyp detection with the Study regimen, but this did not achieve statistical significance for any size category. Mean transit time through the entire gastrointestinal tract, from ingestion to excretion, was shorter with the Study regimen while mean colonic transit times were similar for both study groups. CONCLUSION: A CCE bowel preparation regimen using oral sulfate solution and diatrizoate solution as a boost agent is effective, safe, and achieved superior CCE completion.
Asunto(s)
Endoscopía Capsular/métodos , Catárticos/administración & dosificación , Colon/efectos de los fármacos , Pólipos del Colon/diagnóstico por imagen , Colonoscopía/métodos , Administración Oral , Anciano , Endoscopía Capsular/efectos adversos , Catárticos/efectos adversos , Colon/diagnóstico por imagen , Colonoscopía/efectos adversos , Diatrizoato/administración & dosificación , Diatrizoato/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cuidados Preoperatorios/efectos adversos , Cuidados Preoperatorios/métodos , Estudios Prospectivos , Sulfatos/administración & dosificación , Sulfatos/efectos adversos , Factores de Tiempo , Resultado del TratamientoRESUMEN
PURPOSE: To objectively compare the volume, density, and distribution of luminal fluid for same-day oral-contrast-enhanced CTC following incomplete optical colonoscopy (OC) vs. deferred CTC on a separate day utilizing a dedicated CTC bowel preparation. METHODS: HIPAA-compliant, IRB-approved retrospective study compared 103 same-day CTC studies after incomplete OC (utilizing 30 mL oral diatrizoate) against 151 CTC examinations performed on a separate day after failed OC using a dedicated CTC bowel preparation (oral magnesium citrate/dilute barium/diatrizoate the evening before). A subgroup of 15 patients who had both same-day CTC and separate-day routine CTC was also identified and underwent separate analysis. CTC exams were analyzed for opacified fluid distribution within the GI tract, as well as density and volume. Data were analyzed utilizing Kruskal-Wallis and Wilcoxon Signed Rank tests. RESULTS: Opacified luminal fluid extended to the rectum in 56% (58/103) of same-day CTC vs. 100% (151/151) of deferred separate-day CTC (p < 0.0001). For same-day CTC, contrast failed to reach the colon in 11% (11/103) and failed to reach the left colon in 26% (27/103). Volumetric colonic fluid segmentation for fluid analysis (successful in 80 same-day and 147 separate-day cases) showed significantly more fluid in the same-day cohort (mean, 227 vs. 166 mL; p < 0.0001); the actual difference is underestimated due to excluded cases. Mean colonic fluid attenuation was significantly lower in the same-day cohort (545 vs. 735 HU; p < 0.0001). Similar findings were identified in the smaller cohort with direct intra-patient CTC comparison. CONCLUSIONS: Dedicated CTC bowel preparation on a separate day following incomplete OC results in a much higher quality examination compared with same-day CTC.
Asunto(s)
Colonografía Tomográfica Computarizada/métodos , Neoplasias Colorrectales/diagnóstico , Sulfato de Bario , Catárticos/administración & dosificación , Ácido Cítrico/administración & dosificación , Colonoscopía , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Compuestos Organometálicos/administración & dosificación , Estudios Retrospectivos , Factores de TiempoAsunto(s)
Medios de Contraste/efectos adversos , Diatrizoato/efectos adversos , Erupciones por Medicamentos/diagnóstico , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/patología , Dermatosis Facial/inducido químicamente , Dermatosis Facial/diagnóstico , Dermatosis Facial/patología , Frente , Humanos , Masculino , Tomografía Computarizada por Rayos X/métodosRESUMEN
This study proposes a new methodology to evaluate the putative consequences of the long-lasting circulation in the blood pool of nanoparticulate systems widely used in nanomedicine, Indeed, the blood pool contrast agent for micro-computed tomography, i.e. iodinated nano-emulsions, have recently been developed, for their great potential in medical applications such as advanced diagnosis, image-guided surgery, personalized medicine or theragnostics. Stealth nanoparticles exhibit a low recognition by the reticuloendothelial system, resulting in a prolonged circulation in the bloodstream and long-lasting contact with the endothelium. Therefore, the aim of the present study is to determine whether this prolonged interaction could induce an alteration of the vascular reactivity in rat aorta. The Iodinated nano-emulsions were intravenously injected in anesthetized rats. After 1h of contrast agent circulation in the blood pool, the thoracic aorta was removed for the study of vascular reactivity. These animals were compared with control (untreated) rats and a third group of rats receiving an injection of phosphate buffered saline (i.e. dispersing phase of the nano-emulsions). Phenylephrine-induced concentration-dependent contractions of the isolated rat thoracic aorta were not modified whatever the group. Sodium nitroprusside (a nitric oxide (NO) donor)-induced relaxations of endothelium-denuded aorta were also unaltered in response to the different administrations. In contrast, in comparison with control animals, endothelium-dependent NO-mediated relaxations to acetylcholine were significantly impaired in thoracic aorta from PBS-treated rats, but not in animals receiving the iodinated nano-emulsion. In addition, neither isoprenaline-induced nor levcromakalim-induced relaxations were modified in the aorta from the three groups of animals. These findings indicate that even with a long-lasting residence time of the iodinated nano-emulsion in the blood flow, these iodinated nano-emulsions do not alter the vascular reactivity and thus can be used as contrast agent for preclinical vascular imaging on small laboratory animals.
Asunto(s)
Aorta Torácica/efectos de los fármacos , Medios de Contraste/farmacología , Diatrizoato/farmacología , Nanopartículas , Microtomografía por Rayos X , Animales , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Diatrizoato/análogos & derivados , Relación Dosis-Respuesta a Droga , Emulsiones , Inyecciones Intravenosas , Nanomedicina/métodos , Ratas , Factores de Tiempo , Vasoconstricción/efectos de los fármacos , Vasoconstrictores/farmacología , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacologíaRESUMEN
OBJECTIVE: To assess the palatability of iodinated oral contrast media commonly used in abdominopelvic CT and CT colonography (CTC). METHODS: 80 volunteers assessed the palatability of a 20-ml sample of a standard 30 mg ml(-1) dilution of Omnipaque® (iohexol; GE Healthcare, Cork, Ireland), Telebrix® (meglumine ioxithalamate; Guerbet, Aulnay-sous-Bois, France), Gastromiro® (iopamidol; Bracco, High Wycombe, UK) and Gastrografin® (sodium diatrizoate and meglumine diatrizoate; Bayer, Newbury, UK) in a computer-generated random order. RESULTS: Gastrografin is rated significantly less palatable than the remaining media (p<0.005). Omnipaque and Telebrix are significantly more palatable than Gastromiro. No difference existed between Omnipaque and Telebrix. 39% of participants would refuse to consume the quantities of Gastrografin required for a CTC examination compared with Telebrix (7%) and Omnipaque (9%) (p<0.05). CONCLUSION: Omnipaque and Telebrix are significantly more palatable than both Gastromiro and Gastrografin, with participants more willing to ingest them in larger quantities as well as being less expensive. ADVANCES IN KNOWLEDGE: Omnipaque and Telebrix are significantly more palatable iodinated oral contrast media than both Gastromiro and Gastrografin, which has potential implications in compliance with both abdominopelvic CT and CTC.
Asunto(s)
Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Yotalamato de Meglumina/administración & dosificación , Satisfacción del Paciente/estadística & datos numéricos , Gusto , Ácidos Triyodobenzoicos/administración & dosificación , Administración Oral , Adolescente , Adulto , Diatrizoato de Meglumina/administración & dosificación , Femenino , Humanos , Yohexol/administración & dosificación , Yopamidol/administración & dosificación , Masculino , Adulto JovenRESUMEN
OBJECTIVES: Pelvic arteriovenous malformations (AVMs) are difficult to treat. Arterial embolisation is the most common strategy but often has poor results. We report an alternative surgical approach of controlled intra-operative transvenous embolisation with long-term results in seven cases. MATERIALS AND METHODS: Between 1980 and 2008, we treated seven patients (four men, three women, mean age 50 years). Indications were rectal bleeding (one case), urinary tract problems (four cases), oedema of lower limb (one case) and high-output cardiac failure (one case). Four of them had previous operations and three had previous attempts for embolisation. Embolisation of the malformation was performed through the internal iliac vein. This was done after clamping of all the feeding and draining vessels. The agent used was cyanocrylate (one case), Ethibloc (one case) and bone wax (five cases). RESULTS: Mortality was 0%. Complications occurred in two patients (28,5%), one pulmonary embolism and one regressive femoral paresis. Three patients were re-operated for various reasons. The mean follow-up period was 6 years (1-12 years). Symptoms resolved in all patients, while control by computed tomography (CT) angioscan revealed one residual shunt. CONCLUSION: Complete surgical excision of pelvic AVMs is not always possible. Embolisation does not offer a permanent cure. Intra-operative transvenous embolisation of persisting complex AVMs appears to be an alternative approach with good immediate and long-term results. Ethylene glycol appears to be the most suitable agent.
Asunto(s)
Malformaciones Arteriovenosas/terapia , Embolización Terapéutica , Pelvis/irrigación sanguínea , Procedimientos Quirúrgicos Vasculares , Adulto , Malformaciones Arteriovenosas/diagnóstico por imagen , Malformaciones Arteriovenosas/cirugía , Terapia Combinada , Cianoacrilatos/administración & dosificación , Diatrizoato/administración & dosificación , Combinación de Medicamentos , Embolización Terapéutica/efectos adversos , Embolización Terapéutica/métodos , Ácidos Grasos/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Palmitatos/administración & dosificación , Paris , Glicoles de Propileno/administración & dosificación , Reoperación , Estudios Retrospectivos , Factores de Tiempo , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Ceras , Zeína/administración & dosificaciónRESUMEN
OBJECTIVE: To evaluate the distal extent and attenuation of bowel opacification achieved after administration of a single low volume dose of oral contrast 2 hours before computed tomographic colonography (CTC) after incomplete optical colonoscopy. METHODS: This retrospective study included 144 patients undergoing CTC after incomplete colonoscopy from April 2006 to July 2008 at 2 separate medical centers. Each patient received 20 to 30 mL of diatrizoate meglumine and diatrizoate sodium solution 2 hours before being scanned. RESULTS: The distalmost extent of opacification was: stomach/small bowel, n = 13; cecum, n = 2; ascending colon, n = 7; transverse colon, n = 19; descending colon, n = 14; sigmoid colon, n = 24; rectum, n = 65. The mean attenuation of each opacified segment was: cecum, 449 Hounsfield units (HU); ascending colon, 474 HU; transverse colon, 468 HU; descending colon, 421 HU; sigmoid colon, 391 HU; and rectum, 382 HU. In 103 (71.5%) patients, oral contrast reached the distal colon (descending colon, sigmoid colon, or rectum). The oral contrast did not reach the colon in only 13 (9.0%) patients. CONCLUSIONS: Oral administration of a small volume hyperosmolar oral contrast agent 2 hours before CTC results in satisfactory colonic opacification in the majority of patients. Adding same-day fluid tagging in incomplete colonoscopy patients presenting for completion CTC should result in adequate fluid opacification for most of the colon, especially proximal segments not visualized at the time of incomplete colonoscopy.
Asunto(s)
Enfermedades del Colon/diagnóstico por imagen , Colonografía Tomográfica Computarizada/métodos , Colonoscopía/métodos , Medios de Contraste/administración & dosificación , Diatrizoato de Meglumina/administración & dosificación , Diatrizoato/administración & dosificación , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Catárticos/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Interpretación de Imagen Radiográfica Asistida por Computador , Estudios Retrospectivos , Factores de TiempoRESUMEN
OBJECTIVE: The purpose of the study was to determine whether a difference in patient preference exists between iohexol (Omnipaque) and diatrizoate sodium (Gastroview) as oral contrast medium for abdominal-pelvic CT. A secondary objective was to evaluate whether there are significant differences in bowel opacification and adverse effect profile for the two agents. SUBJECTS AND METHODS: From August 2007 through March 2009, 300 patients were enrolled in this prospective study after informed consent was obtained. Eligible patients were identified from those scheduled for outpatient abdominal-pelvic CT. Subjects were randomly assigned to receive one of two oral contrast agents in a double-blinded fashion. Subjects graded the taste using a 5-point scale, and data regarding demographics, total volume, and adverse effects were collected. A direct comparison of 30 mL of each of the two diluted agents in randomized order was then performed. CT images were graded for bowel opacification by two blinded abdominal radiologists. RESULTS: Of 287 subjects who expressed a preference, 233 patients (81%) preferred dilute iohexol compared with 54 patients (19%) who preferred dilute diatrizoate sodium (p < 0.001). Ten patients had no preference, and three patients did not complete the taste comparison study. No difference in bowel opacification was identified between the oral contrast agents (p = 0.27), nor was there a significant difference in adverse effects (p = 0.352). CONCLUSION: Patents preferred dilute iohexol over dilute diatrizoate sodium for oral contrast for abdominal-pelvic CT. There was no significant difference in bowel opacification or adverse effect profile.
Asunto(s)
Medios de Contraste , Diatrizoato , Intestinos/diagnóstico por imagen , Yohexol , Prioridad del Paciente , Tomografía Computarizada por Rayos X/métodos , Administración Oral , Adulto , Medios de Contraste/administración & dosificación , Diatrizoato/administración & dosificación , Método Doble Ciego , Femenino , Humanos , Yohexol/administración & dosificación , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Imagen de Cuerpo EnteroRESUMEN
PURPOSE: The aim of this study was to compare the quality of low-volume hybrid computed tomography colonography bowel preparation, using both laxatives and oral contrast, with standard polyethylene glycol lavage. METHODS: The study group consisted of 300 consecutive adults (mean age, 58.3 years) who underwent colonoscopy immediately after positive computed tomography colonography. Hybrid bowel preparation for study group was <1 L in total volume, consisting of osmotic cathartic (sodium phosphate or magnesium citrate) in conjunction with oral contrast (2% barium and diatrizoate). A control group of 300 adults (mean age, 58.3 years) underwent primary colonoscopy after standard 4-liter polyethylene glycol lavage without oral contrast. The prospective preparation quality rating by the endoscopist served as the reference standard. A rating of poor/marginal was considered inadequate and adequate/good/excellent was considered diagnostic. RESULTS: The frequency of inadequate bowel preparation was 4.3% (13/300) in the study group vs 12.3% (37/300) for the control group (P < .001). Specifically, preparation was poor or marginal in 10 and 3 cases in the hybrid cohort, respectively, and in 29 and 8 cases in the polyethylene glycol cohort, respectively. Preparation quality was scored as excellent in 32% (96/300) in the hybrid cohort and 23.3% (70/300) in the polyethylene glycol cohort (P < .05). CONCLUSIONS: At colonoscopy, low-volume laxative-oral contrast hybrid preparations are effective for bowel cleansing, perhaps even more so than polyethylene glycol lavage. Beyond improvements in quality, the low-volume preparation may improve patient compliance and would allow for immediate computed tomography colonography if colonoscopy is incomplete, without the need for additional oral contrast tagging.
Asunto(s)
Catárticos/administración & dosificación , Colonoscopía/métodos , Neoplasias Colorrectales/diagnóstico , Medios de Contraste/administración & dosificación , Enema/métodos , Polietilenglicoles/administración & dosificación , Administración Oral , Sulfato de Bario/administración & dosificación , Ácido Cítrico/administración & dosificación , Diatrizoato/administración & dosificación , Combinación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Compuestos Organometálicos/administración & dosificación , Fosfatos/administración & dosificación , Reproducibilidad de los Resultados , Estudios Retrospectivos , Irrigación Terapéutica/métodosRESUMEN
Development of suitable in vitro release models for formulation development as well as quality control purposes has to be initiated in the early design phase of injectable depots. Optimally, construction of an in vitro release model may lead to the establishment of in vitro in vivo correlations. By using a model compound (sodium diatrizoate, DTZ), the purpose of this study was to investigate the possibility of establishing in vitro in vivo relations between the DTZ disappearance profile obtained from the donor compartment of the rotating dialysis cell model and the joint disappearance profile following intra-articular administration. In vitro experiments were conducted by applying solutions of DTZ to the donor compartment. In the in vivo experiments, five horses were subjected to both intravenous and intra-articular administration of an aqueous solution of 3.9 mg DTZ/kg. A strong relation (R(2)=0.99) was obtained between the disappearance data from the donor compartment of the in vitro model and the disappearance data from the synovial fluid after intra-articular administration of DTZ. Furthermore, a relation (R(2)=0.91) between the appearance data obtained from the acceptor compartment and the deconvolved appearance serum data upon intra-articular administration of DTZ was obtained. The correlations obtained in this study hold promise that the rotating dialysis cell model has a role in the prediction of the intra-articular fate of drugs injected as solutions.
Asunto(s)
Cartílago Articular , Diatrizoato/administración & dosificación , Animales , Diatrizoato/farmacocinética , Vías de Administración de Medicamentos , Caballos , Técnicas In VitroRESUMEN
AIM: To assess radiographically irrigant penetration in the root canal system of curved roots during root canal shaping procedures ex vivo. METHODOLOGY: Thirty extracted mandibular molar teeth with moderate to severe curvature were used. A special aiming device was used to guarantee that each successive radiograph was taken with the same positioning. The mesiolingual canal of each tooth was instrumented using the ProTaper system. For each step of the shaping procedure, two irrigation modalities were repeated in the same order. Active irrigation consisted of a 0.5-mL flush of sodium diatrizoate solution (Hypaque 50%) immediately followed by agitation with a size 08 K-file. Passive irrigation consisted of a 0.5-mL flush of sodium hypochlorite solution delivered with a syringe through a 27-gauge notched tip needle. A digital radiograph was taken after each modality and stored on computer for subsequent digital subtraction and measures of the depths of irrigant penetration. Comparisons were performed within an analysis-of-variance framework in a repeated-measures approach. RESULTS: The penetration of irrigants was significantly greater for each successive step of the shaping procedure when the two modalities were analysed separately (P < 0.001). The difference between the two modalities was statistically significant for each step of the shaping procedure (P < 0.0001). CONCLUSIONS: Shaping root canals improved both penetration and exchange of irrigant inside the root canal system. Complete renewal of the solution was impossible to achieve with a conventional syringe delivery system and a limited volume of solution. Recapitulation with a K-file after flushing improved irrigant penetration.
Asunto(s)
Cavidad Pulpar/diagnóstico por imagen , Permeabilidad de la Dentina , Irrigantes del Conducto Radicular , Preparación del Conducto Radicular/métodos , Técnica de Sustracción , Análisis de Varianza , Diatrizoato/administración & dosificación , Humanos , Diente Molar , Radiografía Dental Digital , Irrigantes del Conducto Radicular/administración & dosificación , Hipoclorito de Sodio/administración & dosificación , Estadísticas no Paramétricas , Irrigación Terapéutica/métodosRESUMEN
AIM: To assess irrigant penetration in curved canals after shaping procedures ex vivo. METHODOLOGY: Thirty extracted mandibular molars with moderate to severe root canal curvature were included. A special aiming device was used to guarantee that each successive radiograph was taken with the same positioning. The mesiolingual canal of each tooth was instrumented with ProTaper rotary files. Apical third preparation was completed with an F1 instrument before additional step-back enlargement using F2 then F3 instruments. For each apical taper, the teeth were submitted successively to active irrigation (AI) then to passive irrigation (PI). AI consisted of a 0.5 mL flush of sodium diatrizoate (Hypaque 50%) immediately followed by manual mechanical activation with a gutta-percha point. PI consisted in flushing the canals with sodium hypochlorite passively delivered with a syringe. A digital radiograph was taken after each modality. The influence of needle tip design, needle tip insertion level, irrigant volume, root canal taper and solution activation was assessed by using digital subtraction radiography and measures of the depths of irrigant penetration. Comparisons were performed within an analysis of variance framework in a repeated-measures approach. RESULTS: For PI, all the four explanatory variables 'apical taper', 'volume of irrigant used', 'corono-apical level of needle tip placement', 'needle tip design' had a significant (P < 0.005) influence on outcome of irrigation penetration. CONCLUSIONS: Only active irrigation allowed complete penetration and exchange of irrigating solution. For syringe irrigation alone, the level of needle tip placement in the canal was the most dominating factor.
Asunto(s)
Irrigantes del Conducto Radicular/administración & dosificación , Preparación del Conducto Radicular/instrumentación , Análisis de Varianza , Cavidad Pulpar/diagnóstico por imagen , Permeabilidad de la Dentina , Diatrizoato/administración & dosificación , Diseño de Equipo , Humanos , Diente Molar , Agujas , Radiografía Dental Digital , Reproducibilidad de los Resultados , Hipoclorito de Sodio/administración & dosificación , Estadísticas no Paramétricas , Técnica de Sustracción , Irrigación Terapéutica/métodosRESUMEN
PURPOSE: To establish a pharmacokinetic model for the model drug, sodium diatrizoate (DTZ), allowing joint disappearance kinetics to be estimated from serum appearance kinetics following intra-articular administration, and to calculate the relative joint exposure after intravenous and intra-articular DTZ administration (F(iv/IA)). METHODS: Each of five horses received an aqueous solution of 3.9 mg/kg sodium diatrizoate both intravenously and intra-articularly separated by a one-week wash out period. Serum and synovial samples were collected over 7 h and analyzed for content of model compound using inductively coupled plasma mass spectrometry. RESULTS: Differential equations were used for describing the transport of DTZ between the joint and the central compartment. The three-compartment lag-time model obtained demonstrates that the rate of drug appearance in the systemic circulation equals the rate of disappearance from the joint compartment. Following intravenous and intra-articular administration, an average F(iv/IA) of 0.04% (n = 4) was calculated based on the synovial fluid profiles of DTZ. CONCLUSIONS: This study implies that aspects of the intra-articular fate of DTZ can be obtained from serum data in case synovial fluid samplings are limited, for various possible reasons. The low F(iv/IA) may stimulate future research in the field of intra-articular administration of anti-osteoarthritic drugs.
Asunto(s)
Diatrizoato/sangre , Diatrizoato/farmacocinética , Líquido Sinovial/metabolismo , Animales , Diatrizoato/administración & dosificación , Caballos , Inyecciones Intraarticulares , Inyecciones Intravenosas , Modelos Teóricos , Factores de TiempoRESUMEN
The aim of this study is to assess the long-term results of Ethibloc injection in aneurysmal bone cysts (ABC). Thirty-three patients with ABC were treated with computed tomography-guided percutaneous injection of Ethibloc into the cyst cavity. Twenty-two patients had Ethibloc injection as primary treatment and 11 patients had presented to us with recurrence after previous procedures including steroid injection, bone marrow injection, curettage bone grafting and various other surgical procedures. The mean follow-up was 54 (22-90) months. Symptoms were relieved in all patients. Two patients were lost to follow-up. Eighteen (58%) of the 31 patients followed, had complete resolution of the lesion, 11 (35.5%) patients had partial healing (asymptomatic residual nonprogressive lytic areas). Two (6.5%) patients showed recurrence in the proximal humerus during the follow-up. They are under follow-up but asymptomatic and another two patients encountered more significant complications after the procedure. Ethibloc injection is a relatively simple, minimally invasive alternative procedure for the treatment of ABC, and makes open operation unnecessary by stopping the expansion of the cyst and inducing endosteal new bone formation. This technique may be used as the primary management of ABC's excluding spinal lesions as shown by our largest and longest follow-up study.
Asunto(s)
Quistes Óseos Aneurismáticos/tratamiento farmacológico , Diatrizoato/uso terapéutico , Ácidos Grasos/uso terapéutico , Glicoles de Propileno/uso terapéutico , Soluciones Esclerosantes/uso terapéutico , Zeína/uso terapéutico , Adolescente , Quistes Óseos Aneurismáticos/diagnóstico por imagen , Niño , Preescolar , Diatrizoato/administración & dosificación , Combinación de Medicamentos , Ácidos Grasos/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Inyecciones Intralesiones , Masculino , Glicoles de Propileno/administración & dosificación , Radiografía Intervencional , Soluciones Esclerosantes/administración & dosificación , Prevención Secundaria , Resultado del Tratamiento , Zeína/administración & dosificaciónRESUMEN
AIM: The purpose of this study was to evaluate the safety and efficacy of percutaneous transhepatic portal vein embolization of the right portal vein with an Ethibloc/Lipiodol mixture to induce hypertrophy of the left liver lobe in patients with primarily unresectable liver tumor. METHODS: 15 patients (8 primary liver tumors, 7 liver metastases) underwent portal vein embolization. Liver volumetry, duration of hospitalization, complication rates, relevant laboratory values were documented. RESULTS: In 13/15 patients (84.6%) embolization could be performed with a median of 8.8 ml (range 1.5-28 ml) Ethibloc/Lipiodol. One minor procedure-related complication (subcapsular hematoma) occurred, which did not affect the two-step liver resection. No patient developed acute liver failure after embolization or liver resection. The volume of the left liver lobe increased significantly (p = 0.0015) by 25% from a median of 750 ml (587-1,114 ml) to 967 ml (597-1,249 ml). 11/13 (81.8%) of the embolized patients underwent liver resection at a median of 49 days after embolization. Median hospitalization time was 4 days after embolization and 7 days after liver resection. Median overall survival of the 11 operated patients was 376 days. CONCLUSION: Percutaneous transhepatic portal vein embolization using an Ethibloc/Lipiodol mixture is a safe, feasible, and efficient interventional procedure.
Asunto(s)
Diatrizoato/administración & dosificación , Embolización Terapéutica , Ácidos Grasos/administración & dosificación , Hepatectomía , Aceite Yodado/administración & dosificación , Glicoles de Propileno/administración & dosificación , Soluciones Esclerosantes/administración & dosificación , Zeína/administración & dosificación , Adulto , Anciano , Combinación de Medicamentos , Femenino , Humanos , Regeneración Hepática , Masculino , Persona de Mediana Edad , Vena Porta , Estudios Prospectivos , Resultado del TratamientoRESUMEN
PURPOSE: To determine the feasibility, efficacy, and safety of thermal ablation of the saphenous vein with hot contrast medium. METHODS: Twelve saphenous veins of 6 dogs were percutaneously ablated with hot contrast medium. In all animals, ablation was performed in the vein of one leg, followed by ablation in the contralateral side 1 month later. An occlusion balloon catheter was placed in the infragenicular segment of the saphenous vein via a jugular access to prevent unwanted thermal effects on the non-target segment of the saphenous vein. After inflation of the balloon, 10 ml of hot contrast medium was injected under fluoroscopic control through a sheath placed in the saphenous vein above the ankle. A second 10 ml injection of hot contrast medium was made after 5 min in each vessel. Venographic follow-up of the ablated veins was performed at 1 month (n = 12) and 2 months (n = 6). RESULTS: Follow-up venograms showed that all ablated venous segments were occluded at 1 month. In 6 veins which were followed up to 2 months, 4 (66%) remained occluded, 1 (16%) was partially patent, and the remaining vein (16%) was completely patent. In these latter 2 cases, an inadequate amount of hot contrast was delivered to the lumen due to a closed balloon catheter downstream which did not allow contrast to displace blood within the vessel. DISCUSSION: Hot contrast medium thermal ablation of the saphenous vein appears feasible, safe, and effective in the canine model, provided an adequate amount of embolization agent is used.